Activated H-Ras regulates hematopoietic cell survived by modulating Survivin

被引:19
作者
Fukuda, S [1 ]
Pelus, LM [1 ]
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
关键词
Survivin; Ras; leukemia; apoptosis; cell cycle;
D O I
10.1016/j.bbrc.2004.08.149
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survivin expression and Ras activation are regulated by hematopoietic growth factors. We investigated whether activated Ras could circumvent growth factor-regulated Survivin expression and if a Ras/Survivin axis mediates growth factor independent survival and proliferation in hematopoietic cells. Survivin expression is up-regulated by IL-3 in Ba/F3 and CD34(+) cells and inhibited by the Ras inhibitor, farnesylthiosalicylic acid. Over-expression of constitutively activated H-Ras (CA-Ras) in Ba/F3 cells blocked down-modulation of Survivin expression, G(0)/G(1) arrest, and apoptosis induced by IL-3 withdrawal, while dominant-negative (DN) H-Ras down-regulated Survivin. Survivin disruption by DN T34A Survivin blocked CA-Ras-induced IL-3-independent cell survival and proliferation; however, it did not affect CA-Ras-mediated enhancement of S-phase, indicating that the anti-apoptotic activity of CA-Ras is Survivin dependent while its S-phase enhancing effect is not. These results indicate that CA-Ras modulates Survivin expression independent of hematopoietic growth factors and that a CA-Ras/Survivin axis regulates survival and proliferation of transformed hematopoietic cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:636 / 644
页数:9
相关论文
共 45 条
[1]   Expression and prognostic significance of survivin in de novo acute myeloid leukaemia [J].
Adida, C ;
Recher, C ;
Raffoux, E ;
Daniel, MT ;
Taksin, AL ;
Rousselot, P ;
Sigaux, F ;
Degos, L ;
Altieri, DC ;
Dombret, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :196-203
[2]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[3]   Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma [J].
Aoki, Y ;
Feldman, GM ;
Tosato, G .
BLOOD, 2003, 101 (04) :1535-1542
[4]  
Badran A, 2003, INT J ONCOL, V22, P59
[5]   RAS and leukemia:: From basic mechanisms to gene-directed therapy [J].
Beaupre, DM ;
Kurzrock, R .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :1071-1079
[6]   Signal transducer and activator of transcription proteins in leukemias [J].
Benekli, M ;
Baer, MR ;
Baumann, H ;
Wetzler, M .
BLOOD, 2003, 101 (08) :2940-2954
[7]  
BOS JL, 1989, CANCER RES, V49, P4682
[8]   Cytokine-regulated expression of survivin in myeloid leukemia [J].
Carter, BZ ;
Milella, M ;
Altieri, DC ;
Andreeff, M .
BLOOD, 2001, 97 (09) :2784-2790
[9]   Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions [J].
Conway, EM ;
Pollefeyt, S ;
Cornelissen, J ;
DeBaere, I ;
Steiner-Mosonyi, M ;
Ong, K ;
Baens, M ;
Collen, D ;
Schuh, AC .
BLOOD, 2000, 95 (04) :1435-1442
[10]   Ras proteins in the control of the cell cycle and cell differentiation [J].
Crespo, P ;
León, J .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (11) :1613-1636